At our April Virtual Education Session, rheumatologist Dr Laura Hummers shared expert insights into how scleroderma progresses and how doctors assess individual risk over time.
This session focused on understanding the wide variability of scleroderma, including how factors such as skin type, specific antibodies, and early symptoms help guide monitoring and care. Attendees learned about key complications – including lung disease, renal crisis, and pulmonary arterial hypertension and how these are identified and managed through regular screening. The session also highlighted the importance of early detection, personalised care, and empowering patients to monitor changes, work closely with their healthcare team, and take an active role in managing their condition.
If you or someone you care about has been diagnosed with scleroderma, one of the first questions is often: “What’s going to happen next?”. It’s a completely natural question – but also one of the hardest to answer.
The reality is: there is no single, predictable path for scleroderma.
Each person’s experience is different.
The good news? Doctors do have ways to assess risk, monitor changes, and step in early when needed. This blog breaks that down in a simple, practical way – so you know what matters and what to watch for.
There Is No “Typical” Scleroderma Journey
One of the most important takeaways from recent education sessions is this:
Scleroderma does not follow a standard progression.
- Every person’s disease behaves differently
- Some people experience mild symptoms long-term
- Others may develop complications earlier
You may have heard of the “rule of 15”:
- Around 15% of patients develop major complications
- Around 85% do not
That’s an important and often reassuring perspective.
What Doctors Look At to Predict Progression
Doctors don’t guess – they look for patterns and indicators. This is often called your “phenotype”, meaning your unique combination of disease features.
Here are the key things they assess:
1. Skin Type: Limited vs Diffuse
There are two main types of scleroderma based on skin involvement:
Limited scleroderma:
- Slower progression
- Less internal organ scarring
- More blood vessel-related issues (like Raynaud’s)
Diffuse scleroderma:
- Faster onset
- Higher risk of organ involvement (lungs, kidneys)
- Often more aggressive early stage
- Antibodies (Your Immune “Signature”)
Scleroderma is an autoimmune disease, and specific antibodies can give important clues about risk.
Examples:
- Scl-70 antibody → higher risk of lung fibrosis
- RNA polymerase III antibody → higher risk of kidney complications
These antibodies don’t change over time – but they help guide monitoring and care from the beginning.
3. How Quickly Symptoms Appear
The speed of onset matters.
- Gradual changes → often lower risk
- Rapid changes (over months) → may indicate higher risk
Doctors pay close attention to:
- Skin thickening
- Raynaud’s symptoms
- Swelling or stiffness
The Most Important Complications to Watch For
Not everyone develops complications – but early detection is key.
– Lung Disease (Fibrosis)
This is one of the more common concerns.
How it’s monitored:
- Breathing tests (PFTs)
- CT scans
Important to know:
- Many people have mild lung changes that never worsen
- Only a smaller group develops progressive disease
– Renal Crisis (Rare but Serious)
This is less common (about 3–5% of patients), but very important.
Higher risk if:
- Early diffuse disease
- RNA polymerase III antibody
- Rapid symptom progression
Key action:
Patients at higher risk are advised to monitor blood pressure at home regularly. Early detection makes a major difference in outcomes.
– Pulmonary Arterial Hypertension
- Develops in about 15% of patients
- Usually occurs later in the disease
- Can be serious if not detected early
Doctors use:
- Heart ultrasound (echocardiogram)
- Blood tests
- Breathing tests
Regular screening improves outcomes significantly.
What Patients Can Do to Stay Ahead
This is where you do have control.
Here are simple but powerful steps:
- Attend regular check-ups and screening tests
- Know your antibody type (ask your doctor)
- Monitor blood pressure (if advised)
- Report new or worsening symptoms early
- Stay informed – but avoid overwhelm
Frequently Asked Questions About Scleroderma Progression
1. What does scleroderma progression look like?
Scleroderma progression varies from person to person. Some people experience mild symptoms that remain stable over time, while others may develop complications earlier. There is no single “typical” disease path, which is why regular monitoring is important.
2. Does everyone with scleroderma develop serious complications?
No. Most people do not develop severe complications. Research suggests that around 15% of patients experience major complications, while the majority have a more stable disease course.
3. How do doctors predict scleroderma progression?
Doctors assess a combination of factors, including:
- Skin type (limited or diffuse)
- Specific antibodies
- How quickly symptoms appear
- Results from tests like lung scans and breathing tests
These help determine whether someone is at lower or higher risk.
4. What is the difference between limited and diffuse scleroderma?
- Limited scleroderma tends to progress slowly and is more associated with blood vessel issues.
- Diffuse scleroderma often develops more quickly and may carry a higher risk of internal organ involvement, especially early in the disease.
5. Why do antibodies matter in scleroderma?
Certain antibodies are linked to different risks:
- Some are associated with lung disease
- Others are linked to kidney complications
Knowing your antibody type helps doctors decide how closely to monitor you and what to watch for.
6. What tests are used to monitor scleroderma?
Common monitoring tests include:
- Breathing tests (pulmonary function tests)
- CT scans of the lungs
- Heart ultrasound (echocardiogram)
- Blood tests
- NTProBNP
These help detect complications early – often before symptoms appear.
7. What is scleroderma renal crisis?
Scleroderma renal crisis is a rare but serious complication that can cause a sudden rise in blood pressure and kidney problems. It requires urgent treatment but can be managed effectively if detected early.
8. Should I monitor my blood pressure at home?
Some patients – especially those at higher risk are advised to monitor their blood pressure regularly at home. Your doctor will let you know if this applies to you.
9. What symptoms should I report to my doctor?
You should report any new or worsening symptoms, such as:
- Shortness of breath
- Rapid skin changes
- Severe fatigue
- New ulcers or pain
- Sudden increase in blood pressure
Early reporting helps prevent complications from progressing.
10. Can scleroderma progression be slowed or treated?
While there is no cure, many treatments can help manage symptoms and slow progression in certain cases. Early detection and personalised care make a significant difference.
TL;DR (Quick Summary)
This virtual education session explored how doctors assess and predict scleroderma progression, highlighting that there is no single disease pathway and most patients do not develop severe complications. The session explained how factors such as skin type (limited or diffuse), specific antibodies, and the speed of symptom onset help identify individual risk levels. It also covered key complications – including lung disease, renal crisis, and pulmonary arterial hypertension – and the importance of regular screening and early detection. Participants gained practical guidance on what to monitor, when to seek help, and how to work with healthcare providers to stay proactive and informed throughout their scleroderma journey.
Conclusion
Scleroderma can feel unpredictable – but it’s not unmanaged. With the right monitoring, the right information, and a proactive approach, many complications can be detected early or even prevented from progressing. The most important thing? Stay engaged with your care, ask questions, and don’t ignore changes.
For those living with Scleroderma, staying updated and informed can make a world of difference. Connecting with others can also be hugely beneficial. Find out more about support in your area by clicking here.
If you’d like to gain firsthand knowledge, our National Education Sessions and Virtual Education Sessions are available to you at no charge. Our Virtual Education Sessions are held every month through Google Meet. You can sign up for these free Virtual Education Sessions by clicking here.
These sessions provide an opportunity to engage with medical professionals and seasoned legal experts who will address common inquiries about Scleroderma and related topics.